A 3?-metabolite of progesterone receptor agonist Norethindrone (N676000) that acts as a estrogen receptor agonist in osteoblastic cells. It also has novel nongenomic endothelium-independent vasorelaxi
相关文献及参考
Lemus, A.E. et al.: J. Endocrinol., 200, 199 (2009); Perusquia, M. et al.: Eur. J. Pharmacol., 475, 161 (2003); Blom, M.J. et al.: Drug Metab. Disp., 29, 976 (2001);